SEC Exempt-Offering Integration Rules: A Guide to Rule 152

The Securities and Exchange Commission adopted amendments intended to facilitate capital formation and expand investor access to capital for small and medium-sized businesses and entrepreneurs across the United States (c01). For issuers, the most concrete structural change is a new integration framework: the amendments add new Securities Act Rule 152, which provides a general principle of integration and four non-exclusive safe harbors (c08). The amendments also replaced the integration provisions of several Securities Act exemptions with references to Rule 152 (c09).

In plain terms, the changes determine when separate securities transactions count as one offering, and therefore whether registration under Section 5 of the Securities Act is required or an exemption is available for the whole offering (c06, c07). This guide walks through who is affected, how the new principle works, and what the source does not resolve.

Why integration matters to a raise

The integration doctrine is an analytical framework for deciding whether multiple securities transactions should be considered part of the same offering (c06). That analysis matters because it helps determine whether registration under Section 5 of the Securities Act is required or an exemption is available for the entire offering (c07). If transactions are integrated, registration or exemption status is assessed for the offering as a whole, which is why the analysis matters (c07).

The amendments simplify the integration framework for registered and exempt offerings by adding Rule 152, which provides a general principle of integration and four non-exclusive safe harbors from integration (c08). The Commission also replaced the integration provisions of several Securities Act exemptions with references to Rule 152 (c09) — a drafting change that matters because it points issuers back to one framework rather than scattered exemption-specific language.

Who the amendments reach

The amendments affect any domestic or foreign issuer that seeks to rely on the Commission's exempt offering framework to offer and sell securities without registration under the Securities Act of 1933 (c03). That is a broad reach: it is not limited to US-domiciled companies.

Separately, the Commission revised the confidential information standard applicable to certain exhibit filing requirements (c02). Those revisions affect a variety of entities, including domestic and foreign registrants with offerings registered under the Securities Act or classes of securities registered under the Securities Exchange Act of 1934, Regulation A issuers, and issuers regulated under the Investment Company Act of 1940 (c04). The two changes are related in timing and subject matter but are not the same rule, so they should be read separately.

Author's guidance, not a statement from the source: a company preparing a raise should confirm which change applies to its filing type before assuming both do.

The general principle, in two scenarios

The source describes how the general principle applies in two different settings. First, where an exempt offering prohibits general solicitation: the issuer must have a reasonable belief, based on the facts and circumstances, with respect to each purchaser, that the issuer (or anyone acting on its behalf) either did not solicit that purchaser through general solicitation, or established a substantive relationship with that purchaser before the offering commenced (c11, c12, c13).

Second, the source addresses concurrent exempt offerings that each allow general solicitation (c14). It also states that offers and sales made in compliance with Rule 701, pursuant to an employee benefit plan, or in compliance with Regulation S will not be integrated with other offerings (c15). And it states that offers and sales made in reliance on an exemption for which general solicitation is permitted will not be integrated if made subsequent to any terminated or completed offering (c16).

Timing: commencement and completion

Rule 152(c) provides a non-exclusive list of factors to consider in determining when an offering will be deemed to be commenced, and Rule 152(d) provides factors to consider in determining when an offering will be deemed terminated or completed (c17). Both are factor lists, not bright-line tests.

The rule also cautions issuers that it may not be used as part of a plan or scheme to evade the registration requirements of the Securities Act (c18). In practice, that caution turns documentation and sequencing into substantive questions rather than formalities.

A worked example (Hypothetical)

Consider a Hypothetical US software company that runs a first offering to a limited set of buyers without general solicitation, then a short time later runs a second offering that does permit general solicitation. Under the general principle, for each purchaser in the first offering the company would need a reasonable belief that it either did not solicit that purchaser through general solicitation or had a substantive relationship with that purchaser before the first offering commenced (c11, c12, c13).

For the second offering, the source's safe-harbor language for offers made under an exemption permitting general solicitation after a terminated or completed offering is relevant context (c16), but it does not definitively resolve this exact sequence. The safe harbors are non-exclusive (c08), and whether the first offering was terminated or completed depends on the Rule 152(d) factors (c17). Any conclusion here would be the issuer's own analysis, not an answer supplied by the source.

Checklist for issuers (author's guidance)

• Confirm whether your offering is exempt and whether general solicitation is permitted for it (c03, c14).
• For each purchaser in a no-general-solicitation offering, document your reasonable belief under (c11) through (c13).
• Check whether Rule 701, employee benefit plan, or Regulation S treatment removes an offering from integration analysis (c15).
• Map commencement and completion against the Rule 152(c) and (d) factors (c17).
• Confirm that sequencing is not part of a plan or scheme to evade registration (c18).
• Read exhibit confidentiality changes separately from the integration changes (c02, c04).

What the source does not say

• It does not state effective dates, compliance dates, or transition periods for the amendments.
• It does not give the full text or the four safe harbors by name; only that four non-exclusive safe harbors exist (c08).
• It does not resolve how the general principle treats a no-general-solicitation offering followed by one that permits general solicitation.
• It does not state any market, price, or fundraising figures, and none should be inferred from it.
• It does not specify penalties tied to integration outcomes.
• It does not state whether the exhibit confidentiality revisions share a compliance timeline with the integration changes (c02, c04).

Bottom line

The confirmed change is structural: a new Rule 152 general principle plus four non-exclusive safe harbors, with exemption-specific integration provisions replaced by references to it (c08, c09). The confirmed scope spans any domestic or foreign issuer relying on the exempt offering framework, plus a separate set of entities affected by the confidential information standard revisions (c03, c04). What the source leaves open — dates, safe-harbor names, and mixed-sequence outcomes — is exactly where an issuer's own counsel and documentation carry the weight.

Sources

• sec.gov